Northern Trust Corp Monte Rosa Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $709 Billion
  • Q2 2025

A detailed history of Northern Trust Corp transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 761,419 shares of GLUE stock, worth $5.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
761,419
Previous 373,207 104.02%
Holding current value
$5.28 Million
Previous $1.73 Million 98.32%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$3.7 - $5.33 $1.44 Million - $2.07 Million
388,212 Added 104.02%
761,419 $3.43 Million
Q1 2025

May 13, 2025
SELL
$4.64 - $7.17 $17,432 - $26,937
-3,757 Reduced 1.0%
373,207 $1.73 Million
Q4 2024

Feb 14, 2025
BUY
$4.8 - $10.36 $88,276 - $190,530
18,391 Added 5.13%
376,964 $2.62 Million
Q3 2024

Nov 13, 2024
BUY
$3.59 - $6.97 $231,113 - $448,707
64,377 Added 21.88%
358,573 $1.9 Million
Q2 2024

Aug 14, 2024
BUY
$3.38 - $7.86 $12,647 - $29,412
3,742 Added 1.29%
294,196 $1.1 Million
Q1 2024

May 14, 2024
BUY
$4.26 - $8.46 $23,515 - $46,699
5,520 Added 1.94%
290,454 $2.05 Million
Q4 2023

Feb 13, 2024
SELL
$2.5 - $5.93 $397,570 - $943,036
-159,028 Reduced 35.82%
284,934 $1.61 Million
Q3 2023

Nov 13, 2023
BUY
$4.78 - $7.22 $73,960 - $111,715
15,473 Added 3.61%
443,962 $2.13 Million
Q2 2023

Aug 11, 2023
BUY
$4.53 - $8.4 $806,167 - $1.49 Million
177,962 Added 71.04%
428,489 $2.94 Million
Q1 2023

May 15, 2023
SELL
$5.95 - $8.21 $27,274 - $37,634
-4,584 Reduced 1.8%
250,527 $1.95 Million
Q4 2022

Feb 13, 2023
BUY
$6.71 - $9.72 $46,708 - $67,660
6,961 Added 2.81%
255,111 $1.94 Million
Q3 2022

Nov 14, 2022
BUY
$7.17 - $12.16 $174,840 - $296,521
24,385 Added 10.9%
248,150 $2.03 Million
Q2 2022

Aug 12, 2022
BUY
$6.15 - $14.99 $24,766 - $60,364
4,027 Added 1.83%
223,765 $2.16 Million
Q1 2022

May 13, 2022
BUY
$10.36 - $20.41 $1.16 Million - $2.28 Million
111,573 Added 103.15%
219,738 $3.08 Million
Q4 2021

Feb 08, 2022
BUY
$16.28 - $27.15 $67,855 - $113,161
4,168 Added 4.01%
108,165 $2.21 Million
Q3 2021

Nov 15, 2021
BUY
$18.59 - $42.21 $1.93 Million - $4.39 Million
103,997 New
103,997 $2.32 Million

Others Institutions Holding GLUE

# of Institutions
114
Shares Held
58.3M
Call Options Held
56.3K
Put Options Held
0
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $324M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email